Jaguar Health (JAGX) Enterprise Value (2014 - 2026)
Jaguar Health's (JAGX) quarterly Enterprise Value came in at -$11.6 million in Q1 2026, down 75.22% year-on-year from -$47.0 million in Q1 2025, and down 26.08% on a QoQ basis from -$9.2 million in Q4 2025.
Jaguar Health (JAGX) Enterprise Value (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Enterprise Value data on file, last reported at -$11.6 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 75.22% year-over-year to -$11.6 million in Q1 2026; TTM through Mar 2026 was -$11.6 million, a 75.22% decrease from a year earlier, with the FY2025 full-year figure at -$9.2 million, down 4.98% from the prior year.
- Enterprise Value for Q1 2026 stood at -$11.6 million, down from -$9.2 million in the prior quarter.
- Over the last five years, Enterprise Value for JAGX reached as high as -$3.2 million in Q3 2023 and fell as low as -$17.4 million in Q1 2022.
- Historically, Enterprise Value has averaged -$9.5 million across 5 years, with a median of -$9.0 million in 2022.
- Across the five-year window, Enterprise Value slumped 334.79% in 2024 and soared 79.76% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$5.2 million in 2022, then fell by 24.99% to -$6.5 million in 2023, then sank by 34.59% to -$8.8 million in 2024, then decreased by 4.98% to -$9.2 million in 2025, then fell by 26.08% to -$11.6 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$11.6 million in Q1 2026, -$9.2 million in Q4 2025, and -$4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,810.93 Bn | 1,810.87 Bn | - | -60.03 Mn |
| 2 | Akari Therapeutics | 997.56 Bn | 997.56 Bn | - | -2.83 Mn |
| 3 | BeOne Medicines | 475.29 Bn | 470.50 Bn | 1.35 Bn | -4.79 Bn |
| 4 | Vertex Pharmaceuticals | 124.40 Bn | 117.15 Bn | 2.59 Bn | -7.25 Bn |
| 5 | Regeneron Pharmaceuticals | 72.15 Bn | 63.40 Bn | 3.31 Bn | -8.75 Bn |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - | - |
| 7 | Argenx Se | 54.26 Bn | 49.08 Bn | 1.41 Bn | -5.18 Bn |
| 8 | Alnylam Pharmaceuticals | 38.21 Bn | 35.20 Bn | 959.66 Mn | -3.01 Bn |
| 9 | Revolution Medicines | 36.28 Bn | 36.28 Bn | - | -1.91 Bn |
| 10 | Jaguar Health | 513,982.75 | -9.55 Mn | 19.11 Mn | -11.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.64 Mn |
| Dec 31, 2025 | -9.23 Mn |
| Sep 30, 2025 | -4.80 Mn |
| Jun 30, 2025 | -3.32 Mn |
| Mar 31, 2025 | -6.64 Mn |
| Dec 31, 2024 | -8.79 Mn |
| Sep 30, 2024 | -13.78 Mn |
| Jun 30, 2024 | -16.38 Mn |
| Mar 31, 2024 | -11.85 Mn |
| Dec 31, 2023 | -6.53 Mn |
| Sep 30, 2023 | -3.17 Mn |
| Jun 30, 2023 | -8.44 Mn |
| Mar 31, 2023 | -14.06 Mn |
| Dec 31, 2022 | -5.23 Mn |
| Sep 30, 2022 | -10.61 Mn |
| Jun 30, 2022 | -8.97 Mn |
| Mar 31, 2022 | -17.39 Mn |
| Dec 31, 2021 | -16.81 Mn |
| Sep 30, 2021 | -12.38 Mn |
| Jun 30, 2021 | -9.92 Mn |